X

Vous n'êtes pas connecté

Maroc Maroc - FINANCIALPOST.COM - A La Une - 23/Jun 16:08

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

Mezagitamab-Treated Patients Showed Rapid and Sustained Increases in Platelet Counts That Persisted 8 Weeks After the Last Dose Through to Week 161 Mezagitamab Had a Favorable Safety Profile, with No New Safety Signals1 Takeda Plans to Initiate Global Phase 3 Trial of Mezagitamab in ITP in the Second Half of FY2024 OSAKA, Japan & CAMBRIDGE, […]

Articles similaires

Sorry! Image not available at this time

Close to $2B being invested to boost potable water access in Region Two

guyanachronicle.com - 30/Jun 09:40

THE government is investing a minimum of $2 billion to boost treated water coverage in Region Two, demonstrating the government’s mandate to provide...

Sorry! Image not available at this time

First Patient Dosed in the MAD Part 2 Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity

drugs.com - 26/Jun 19:06

CAMBRIDGE, Mass., June 26, 2024. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic...

Sorry! Image not available at this time

Takeda Announces New Assignments of Directors

financialpost.com - 26/Jun 07:13

OSAKA, Japan — Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting and at the...

Sorry! Image not available at this time

Pakistan announces start of second phase of expelling undocumented Afghan refugees

khaama.com - 01/Jul 06:39

According to international media reports, Pakistan will initiate the second phase of the contentious expulsion of undocumented Afghan migrants. Al...

Imugene delivers first combo dose in bile tract cancer study

thewest.com.au - 24/Jun 08:20

Imugene has confirmed the delivery of its first “onCARlytics” combination therapy dose to a bile duct cancer patient in the initial phase of a...

Police make arrest in multiple incidents of arson in Cambridge

cambridgetoday.ca - 23/Jun 15:13

Man faces three counts of arson, as well a break and enter and mischief charges

Program to enhance safety and reduce bear attractants launched

e-know.ca - 04/Jul 18:28

In a continued effort to enhance community safety and reduce bear attractants, we are excited to announce the latest phase of a cost-share program...

SAMRO Increases its Radio and General Royalty Distribution by 62.42% to R242 Million

social-tv.co.za - 27/Jun 15:28

The Southern African Music Rights Organisation (SAMRO) has successfully distributed a staggering R242 million for the Radio and General (R&G) Category...

Sorry! Image not available at this time

EG 427 receives US FDA clearance to initiate phase 1b/2a study of gene therapy, EG110A to treat NDO in spinal cord injury patients

pharmabiz.com - 26/Jun 00:00

EG 427, a biotechnology company leading the development of pinpoint DNA medicines for prevalent diseases in neurology based on its unique...

Sorry! Image not available at this time

Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg

drugs.com - 02/Jul 04:07

DAEJEON, South Korea, July 2, 2024. PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing...